Design and analysis issues of multiregional clinical trials with different regional primary endpoints

Hsiao-Hui Tsou1, Yi Tsong, Wan-Jung Chang

  • 1Division of Biostatistics and Bioinformatics, Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Miaoli County, Taiwan. tsouhh@nhri.org.tw

Insights

Designing multiregional clinical trials (MRCTs) for two primary endpoints presents challenges. This study systematically compares various approaches for hypothesis testing, error rate control, and sample size determination to meet diverse regional requirements.

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Drug Development

Background:

  • Multiregional clinical trials (MRCTs) face challenges in satisfying diverse regional requirements for primary endpoints.
  • Designing and analyzing trials with multiple primary endpoints requires careful consideration of statistical methodologies.

Purpose of the Study:

  • To systematically compare different statistical approaches for multiregional clinical trials (MRCTs) with two primary endpoints.
  • To address the objective of satisfying distinct regional requirements for primary endpoints in drug development programs.

Main Methods:

  • Utilized data from a standard fixed-size, well-controlled parallel arm trial.
  • Evaluated sequential and simultaneous testing of two null hypotheses for distinct, correlated endpoints.
  • Compared various type I error rate adjustment strategies and sample size/power determination methods.

Main Results:

  • Demonstrated systematic comparisons of different statistical approaches for MRCTs with dual primary endpoints.
  • Highlighted the impact of hypothesis structure and error rate control on overall trial design.
  • Discussed the implications for obtaining regional regulatory approval based on varied endpoint requirements.

Conclusions:

  • Various statistical methods exist for designing and analyzing MRCTs with two primary endpoints.
  • Systematic comparison aids in selecting appropriate approaches to meet diverse regional regulatory demands.
  • The choice of testing strategy and error control significantly influences trial outcomes and approval.

Related Concept Videos

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...